Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (299)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
64
2024
3035
6.880
Why?
Antibodies, Bispecific
4
2024
43
1.550
Why?
Leukemia, Plasma Cell
2
2020
34
1.440
Why?
Bone Marrow
11
2024
411
1.440
Why?
Neoplasms, Plasma Cell
3
2024
39
1.390
Why?
Paraproteinemias
2
2022
80
1.370
Why?
Neoplasm, Residual
6
2022
166
1.220
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2023
108
1.180
Why?
Hematopoietic Stem Cell Transplantation
5
2024
573
1.130
Why?
Immunoglobulin Light Chains
2
2017
101
1.100
Why?
Humans
78
2024
54284
0.970
Why?
Myelodysplastic Syndromes
5
2016
79
0.970
Why?
Immunoconjugates
2
2022
38
0.950
Why?
Mutation
8
2022
1501
0.880
Why?
Leukemia, Myeloid, Acute
4
2019
191
0.840
Why?
Antibodies, Monoclonal
6
2023
562
0.810
Why?
Gene Expression Profiling
10
2023
1138
0.760
Why?
Testis
1
2021
65
0.760
Why?
Prognosis
15
2024
2118
0.750
Why?
Gene Expression Regulation, Neoplastic
8
2021
866
0.740
Why?
Hematopoietic Stem Cells
3
2019
215
0.710
Why?
B-Cell Maturation Antigen
6
2024
72
0.690
Why?
Clonal Evolution
4
2024
60
0.680
Why?
Cell Proliferation
8
2023
1096
0.670
Why?
Gene Expression
3
2018
664
0.650
Why?
Clinical Trials as Topic
6
2023
490
0.600
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1056
0.590
Why?
Translocation, Genetic
5
2021
287
0.580
Why?
Thoracic Neoplasms
1
2016
11
0.560
Why?
Plasmacytoma
1
2016
47
0.540
Why?
Receptors, Interleukin-8B
1
2015
4
0.530
Why?
Interleukin-8
1
2015
97
0.510
Why?
Aged
19
2023
10054
0.500
Why?
Plasma Cells
5
2023
238
0.470
Why?
Survival Analysis
7
2021
735
0.450
Why?
Antineoplastic Agents
7
2024
1300
0.440
Why?
Combined Modality Therapy
4
2024
692
0.430
Why?
Signal Transduction
4
2021
1753
0.430
Why?
Fluorodeoxyglucose F18
5
2021
205
0.420
Why?
Neutropenia
2
2023
120
0.420
Why?
DNA Methylation
4
2020
574
0.420
Why?
Male
24
2021
27334
0.410
Why?
Oncogene Proteins, Fusion
2
2018
60
0.410
Why?
Transplantation, Autologous
6
2024
476
0.400
Why?
Polycomb Repressive Complex 2
2
2021
50
0.390
Why?
Chromosomes, Human, Pair 1
3
2023
113
0.390
Why?
Middle Aged
18
2021
13088
0.390
Why?
Epigenesis, Genetic
4
2020
399
0.380
Why?
Stem Cell Transplantation
3
2022
196
0.380
Why?
Positron-Emission Tomography
4
2022
322
0.380
Why?
Evolution, Molecular
2
2021
103
0.380
Why?
Adult
15
2022
14207
0.370
Why?
Tretinoin
1
2010
56
0.360
Why?
Neoplasm Recurrence, Local
6
2024
644
0.350
Why?
Immunoglobulin kappa-Chains
2
2021
31
0.340
Why?
Transcription Factors
3
2023
622
0.330
Why?
Aged, 80 and over
7
2021
3431
0.310
Why?
Tumor Microenvironment
3
2023
209
0.300
Why?
DNA-Binding Proteins
2
2021
462
0.300
Why?
Neoplasm Proteins
3
2020
359
0.300
Why?
Melanoma
1
2010
313
0.290
Why?
Transcriptome
2
2020
346
0.290
Why?
Female
21
2021
28441
0.280
Why?
Treatment Outcome
8
2022
5604
0.280
Why?
Disease Progression
7
2023
913
0.270
Why?
Biopsy
2
2018
692
0.260
Why?
Radiopharmaceuticals
3
2021
238
0.250
Why?
Cell Line, Tumor
5
2023
1550
0.250
Why?
Dexamethasone
3
2024
435
0.250
Why?
Skin Neoplasms
1
2010
532
0.250
Why?
Pentaerythritol Tetranitrate
1
2024
6
0.250
Why?
Kaplan-Meier Estimate
3
2021
514
0.240
Why?
T-Lymphocytes
5
2024
373
0.240
Why?
Mutation Rate
2
2021
40
0.240
Why?
Receptors, G-Protein-Coupled
1
2024
55
0.240
Why?
Myeloproliferative Disorders
1
2023
28
0.230
Why?
Cell Cycle
2
2021
275
0.220
Why?
Proto-Oncogene Proteins B-raf
2
2020
90
0.210
Why?
Genomics
2
2023
310
0.210
Why?
Drug Approval
1
2022
47
0.210
Why?
Osteolysis
1
2022
88
0.210
Why?
Waldenstrom Macroglobulinemia
1
2022
41
0.210
Why?
Lymphoma, B-Cell
1
2022
62
0.200
Why?
Hematologic Diseases
1
2021
25
0.200
Why?
Epigenomics
1
2021
67
0.200
Why?
Bone Marrow Transplantation
1
2022
149
0.200
Why?
Patient Participation
1
2022
70
0.200
Why?
Abnormal Karyotype
1
2021
6
0.200
Why?
Chromosome Deletion
2
2023
150
0.200
Why?
Myeloma Proteins
1
2021
26
0.200
Why?
Immunoglobulin A
1
2021
54
0.190
Why?
Drug Design
2
2013
133
0.190
Why?
Diffusion Magnetic Resonance Imaging
2
2019
126
0.190
Why?
Communicable Diseases
1
2021
58
0.190
Why?
Gene Expression Regulation, Leukemic
1
2020
36
0.190
Why?
Antibodies, Monoclonal, Humanized
1
2022
240
0.190
Why?
Hematologic Neoplasms
1
2022
99
0.190
Why?
Genes, Tumor Suppressor
2
2021
85
0.190
Why?
Salvage Therapy
1
2021
145
0.190
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
14
0.180
Why?
Immunoglobulin G
1
2021
226
0.180
Why?
Practice Guidelines as Topic
1
2023
492
0.180
Why?
Neoplasm Invasiveness
1
2021
295
0.180
Why?
Bone Resorption
1
2022
326
0.180
Why?
Gene Amplification
1
2019
57
0.180
Why?
Chromosomal Instability
1
2019
17
0.180
Why?
Bone Diseases
1
2021
109
0.180
Why?
Hematopoiesis, Extramedullary
1
2019
10
0.180
Why?
Gene Regulatory Networks
1
2020
124
0.180
Why?
Atrial Fibrillation
1
2022
197
0.170
Why?
Neoplasms, Second Primary
1
2019
77
0.170
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
11
0.170
Why?
Healthcare Disparities
1
2022
271
0.170
Why?
Comorbidity
1
2021
663
0.170
Why?
Risk Assessment
3
2019
1361
0.160
Why?
Sulfonamides
1
2019
146
0.160
Why?
Spleen
1
2019
186
0.160
Why?
Models, Statistical
1
2020
259
0.160
Why?
Spinal Fractures
1
2018
41
0.160
Why?
Phosphotransferases
1
2018
24
0.160
Why?
Immunotherapy, Adoptive
3
2024
134
0.160
Why?
Risk Factors
7
2021
3935
0.160
Why?
Bacteremia
1
2019
101
0.160
Why?
Adipocytes
1
2018
129
0.160
Why?
Gene Rearrangement
1
2018
76
0.150
Why?
Kidney Function Tests
1
2017
59
0.150
Why?
Hexokinase
1
2017
18
0.150
Why?
Cell Differentiation
3
2022
720
0.150
Why?
Disease-Free Survival
4
2019
485
0.150
Why?
Chromosomes, Human, Pair 17
1
2017
43
0.150
Why?
Calcification, Physiologic
1
2017
42
0.150
Why?
Glomerular Filtration Rate
1
2017
138
0.150
Why?
Histoplasma
1
2016
29
0.150
Why?
Pelvis
1
2017
76
0.150
Why?
Survival Rate
4
2020
951
0.150
Why?
CA-125 Antigen
1
2016
20
0.140
Why?
Chromosome Aberrations
2
2023
316
0.140
Why?
Receptor, TIE-2
1
2016
18
0.140
Why?
HIV Infections
1
2021
394
0.140
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.140
Why?
Urea
1
2016
83
0.140
Why?
Histoplasmosis
1
2016
53
0.140
Why?
Indazoles
1
2016
55
0.140
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
99
0.140
Why?
Gene Expression Regulation, Enzymologic
1
2017
206
0.130
Why?
Gastrointestinal Diseases
1
2016
126
0.130
Why?
Tumor Suppressor Protein p53
1
2017
250
0.130
Why?
Mice
4
2024
6413
0.130
Why?
Proteasome Inhibitors
1
2016
110
0.130
Why?
Cell Cycle Checkpoints
1
2015
35
0.130
Why?
Immunologic Factors
1
2016
130
0.130
Why?
Xenograft Model Antitumor Assays
1
2015
219
0.120
Why?
Cluster Analysis
1
2015
249
0.120
Why?
Thrombopoiesis
1
2014
8
0.120
Why?
Hydrazines
1
2014
16
0.120
Why?
Recurrence
4
2021
690
0.120
Why?
Benzoates
1
2014
22
0.120
Why?
Myocardium
1
2017
441
0.120
Why?
Time Factors
2
2021
3213
0.120
Why?
Neoplastic Stem Cells
1
2015
103
0.120
Why?
Kidney Diseases
1
2017
293
0.120
Why?
Immunotherapy
1
2016
263
0.120
Why?
Cystatin M
2
2024
21
0.120
Why?
Animals
6
2024
14385
0.110
Why?
Pyrazoles
1
2014
110
0.110
Why?
Cross-Sectional Studies
3
2023
1693
0.110
Why?
Cell Survival
1
2015
657
0.110
Why?
Chromosomes, Human, Pair 7
1
2012
30
0.110
Why?
Disease Models, Animal
2
2016
1639
0.110
Why?
Clone Cells
2
2023
89
0.110
Why?
STAT3 Transcription Factor
1
2012
87
0.110
Why?
Cardiovascular Diseases
1
2017
476
0.100
Why?
Cell Transformation, Neoplastic
1
2013
200
0.100
Why?
Thalidomide
1
2014
397
0.100
Why?
Follow-Up Studies
3
2024
2387
0.100
Why?
Flow Cytometry
2
2012
546
0.100
Why?
Leukemia, Promyelocytic, Acute
1
2010
10
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
278
0.090
Why?
Response Elements
1
2010
32
0.090
Why?
Luciferases
1
2010
57
0.090
Why?
Gene Silencing
1
2010
129
0.090
Why?
Alleles
2
2021
277
0.090
Why?
Tumor Burden
2
2020
142
0.090
Why?
Recombinant Fusion Proteins
1
2010
206
0.090
Why?
Transfection
1
2010
399
0.090
Why?
Molecular Structure
1
2010
319
0.090
Why?
Retrospective Studies
4
2024
6432
0.090
Why?
Histones
2
2021
335
0.080
Why?
DNA Copy Number Variations
2
2021
114
0.080
Why?
Apoptosis
2
2014
1300
0.080
Why?
Syndecan-1
2
2021
82
0.080
Why?
Remission Induction
2
2021
221
0.080
Why?
Tumor Cells, Cultured
2
2020
477
0.070
Why?
Imaging, Three-Dimensional
2
2017
171
0.070
Why?
Gene Expression Regulation
1
2010
1062
0.060
Why?
Arkansas
2
2021
2100
0.060
Why?
Ferritins
1
2024
31
0.060
Why?
Myeloid Progenitor Cells
1
2023
19
0.060
Why?
X-Ray Microtomography
1
2024
82
0.060
Why?
Receptors, Antigen, T-Cell
1
2023
50
0.060
Why?
Demography
1
2023
99
0.060
Why?
Antibodies
1
2024
178
0.060
Why?
Cell Communication
1
2023
72
0.060
Why?
TNF Receptor-Associated Factor 3
1
2022
14
0.060
Why?
Neoplasms
1
2013
1316
0.050
Why?
Patients
1
2022
53
0.050
Why?
Geography
1
2022
81
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
40
0.050
Why?
United States Food and Drug Administration
1
2022
97
0.050
Why?
Oncogenes
1
2021
63
0.050
Why?
Patient Selection
1
2023
286
0.050
Why?
United States
2
2023
5217
0.050
Why?
Phylogeny
1
2022
269
0.050
Why?
Infant
1
2010
3817
0.050
Why?
RANK Ligand
1
2022
183
0.050
Why?
SOXC Transcription Factors
1
2021
14
0.050
Why?
Transcriptional Activation
1
2021
134
0.050
Why?
Tomography, X-Ray Computed
2
2017
1213
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.050
Why?
Chromatin
1
2021
156
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
23
0.050
Why?
Proto-Oncogene Proteins c-maf
1
2020
20
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.050
Why?
Pyrimidines
1
2022
196
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
105
0.050
Why?
Histone Code
1
2020
32
0.050
Why?
Cyclin D1
1
2020
60
0.050
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
Why?
ras Proteins
1
2020
70
0.050
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.050
Why?
Protein Kinase Inhibitors
1
2022
216
0.050
Why?
Genome, Human
1
2021
131
0.050
Why?
DNA, Neoplasm
1
2020
171
0.050
Why?
Health Status Disparities
1
2022
219
0.040
Why?
DNA Mutational Analysis
1
2020
217
0.040
Why?
Osteoclasts
1
2022
469
0.040
Why?
Genetic Variation
1
2020
253
0.040
Why?
Multivariate Analysis
1
2021
643
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
206
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
36
0.040
Why?
Computational Biology
1
2020
231
0.040
Why?
Fractures, Compression
1
2018
19
0.040
Why?
Syndrome
1
2019
252
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
596
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Promoter Regions, Genetic
1
2020
520
0.040
Why?
Protein-Tyrosine Kinases
1
2018
101
0.040
Why?
False Positive Reactions
1
2017
68
0.040
Why?
Bone and Bones
1
2021
516
0.040
Why?
Databases, Factual
1
2020
684
0.040
Why?
beta-Glucans
1
2016
26
0.040
Why?
Itraconazole
1
2016
45
0.040
Why?
Alkaline Phosphatase
1
2017
99
0.040
Why?
Genes, ras
1
2016
48
0.040
Why?
Angiopoietin-1
1
2016
18
0.040
Why?
Genes, p53
1
2016
60
0.040
Why?
Amino Acid Sequence
1
2018
767
0.040
Why?
Amphotericin B
1
2016
122
0.040
Why?
Intestinal Obstruction
1
2016
37
0.040
Why?
Glycolysis
1
2016
73
0.040
Why?
Ileum
1
2016
102
0.040
Why?
Colonoscopy
1
2016
105
0.030
Why?
NF-kappa B
1
2018
335
0.030
Why?
Gene Knockdown Techniques
1
2016
125
0.030
Why?
Genomic Instability
1
2016
95
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
142
0.030
Why?
Fever
1
2016
129
0.030
Why?
Models, Genetic
1
2016
209
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
119
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
153
0.030
Why?
Staphylococcal Infections
1
2019
300
0.030
Why?
Logistic Models
1
2018
995
0.030
Why?
Proportional Hazards Models
1
2016
431
0.030
Why?
Heart
1
2017
360
0.030
Why?
Echocardiography
1
2017
392
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Algorithms
1
2018
697
0.030
Why?
Weight Loss
1
2016
271
0.030
Why?
Longitudinal Studies
1
2016
746
0.030
Why?
Antifungal Agents
1
2016
363
0.030
Why?
Models, Immunological
1
2013
10
0.030
Why?
Chemistry, Pharmaceutical
1
2013
39
0.030
Why?
Early Diagnosis
1
2013
96
0.030
Why?
Azacitidine
1
2012
37
0.030
Why?
Karyotyping
1
2012
92
0.030
Why?
Primary Cell Culture
1
2012
65
0.030
Why?
Cell Lineage
1
2012
93
0.030
Why?
Polymerase Chain Reaction
1
2013
531
0.020
Why?
Antigens, CD
1
2012
242
0.020
Why?
Enzyme Inhibitors
1
2013
446
0.020
Why?
Magnetic Resonance Imaging
1
2017
1604
0.020
Why?
Neoplasm Staging
1
2013
806
0.020
Why?
Cytokines
1
2013
676
0.020
Why?
Reproducibility of Results
1
2013
1304
0.020
Why?
Case-Control Studies
1
2012
1228
0.020
Why?
Cohort Studies
1
2013
1543
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description